We explored this in the context of Wnt/β-catenin pathway genes, as CCS tumor cells have a known Wnt dependency7; however, we could not conclusively prove a link between DNMT3A mutation and Wnt signalling using our models. The gene discussed is DNMT3A; the disease is neoplasm.